S3V Vascular Technologies Limited, founded in 2011 and headquartered in Mysore, Karnataka, is a medical device manufacturer focused on advanced cardiovascular and critical-care products, operating through a fully integrated model that combines in-house research and development, proprietary technology and regulated manufacturing facilities. It became the first company to receive a manufacturing license for an expandable titanium-based intervertebral body fusion device (expandable spinal cage), with the first successful implant performed in Pune, and is currently the only manufacturer globally offering this specific expandable cage. Its product portfolio includes drug-eluting and bare-metal stents, PTCA and neurovascular catheters, esophageal and biliary stents, and India’s first indigenous mechanical thrombectomy device for stroke treatment, aiming to reduce import dependence and improve affordability in a market largely dominated by imported devices. Led by promoter Badari Narayan, a m...
Fundamentals
S3V Vascular Technologies Limited Price
₹445.00 Per Equity Share
Lot Size
500 Shares
52 Week High
445 Shares
52 Week Low
350 Shares
Depository
NSDL & CDSL
PAN Number
AAQCS2303F
ISIN Number
INE0HGT01012
CIN
U33112KA2011PLC059915
RTA
Aarthi Consultants
Market Cap (in Cr.)
853.00
P/E Ratio
0.00
P/B Ratio
5.65
D/E Ratio
0.18
ROE
-2.26
Book Value
78.82
Face Value
10.00
Total Shares
19178590
Financials (Figures in ₹ Cr)
P&L Statement
Field
2022
2023
2024
da
1.5
1.7
2.07
eps
2.08
0.42
-1.66
npm
12.86
2.95
-21.27
opm
27.62
19.47
16.67
pat
2.7
0.56
-3.19
pbt
2.8
0.65
-3.06
tax
0.1
0.09
0.13
ebit
4.3
2
0.43
ebitda
5.8
3.7
2.5
revenue
21
19
15
pbt margins
13.33
3.42
-20.4
ebit margins
20.48
10.53
2.87
finance cost
1.4
1.3
3.5
other income
0.09
0.08
0.2
gross margins
63.33
58.42
63.33
other expenses
5.5
4.8
4
change in inventory
1.1
-0.6
0.8
cost of material consumed
6.6
8.5
4.7
employee benefit expenses
2
2.6
3
Shareholding Pattern
Events
Name
S3V's Allotment of CCPS of ₹8.45 Cr corporate_action Allotment of 4,80,123 Non-Cumulative Compulsorily Convertible Preference Shares (CCPS) on a preferential basis. (26/03/2024)
S3V's Allotment of CCPS of ₹89.92 Cr corporate_action Allotment of 51,09,183 CCPS @176/share on a preferential basis. (13/03/2024)
Promoters or Management
Name
Designation
Exp.
Badari Narayan
MD & CEO
25+
Vijaya Gopal Nagaradagadde
Director, Co-founder
15+
We use cookies to improve your experience and analyze site usage. By continuing, you agree to ourPrivacy Policy